Elder Pharmaceuticals likely to launch 32-35 new products

06 Jun 2011 Evaluate

Elder Pharmaceuticals, leading company in the pharmaceutical formulation plans to launch almost three dozen new products in the coming 30 months. The company has earmarked an investment of about Rs 120-130 crore for this product launches.

In coming 30 months the company is likely to launch almost 32-35 new products in niche therapeutic segments like female healthcare, osteoporosis, dermatology, pain management, cardiology, nutraceuticals, wound care and vitamin supplements. The company’s larger focus will be on self-researched products but it will consist of a combination of in-licensed and own products. The company’s scientists are also working on new products, new drug delivery systems and combination therapies in niche therapeutic segments like osteoporosis, dermatology, cardiology, pain management, wound care, vitamin supplements and aim at launching at least 3-4 new products in each of these segments.

The entity is also looking at the wound care and pain management segments which currently contribute about 16% to Elder's turnover and anticipated to grow at over 15% every year. It is in talks with about 4-5 international companies for launching their world renowned products in India and South Asia.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×